LeadIQ logo
Learn more at LeadIQ.com

Insights

Partnership Expansion Andelyn Biosciences has recently expanded its partnerships with Gtexportal and Grace Science LLC, indicating a focus on collaboration and potential for further collaborations with complementary organizations.

Key Personnel Promotion The promotion of Cyrill Kellerhals to Chief Operations Officer highlights the company's commitment to internal talent development and presents an opportunity for building relationships at the executive level.

Client Acquisition Securing Ultragenyx Pharmaceutical Inc. as a new client showcases Andelyn Biosciences' ability to attract prominent players in the industry, suggesting potential growth opportunities through client referrals and industry recognition.

University Collaboration Collaborating with The Ohio State University Gene Therapy Institute positions Andelyn Biosciences as a key player in academia-industry partnerships, offering avenues for research collaborations and access to a pool of scientific expertise.

Therapy Development The company's involvement in developing AAV therapies for various gene therapy programs signifies a commitment to innovation and R&D, creating opportunities for discussions around emerging therapies and future partnerships.

Similar companies to Andelyn Biosciences

Andelyn Biosciences Tech Stack

Andelyn Biosciences uses 8 technology products and services including Hotjar, jsDelivr, MySQL, and more. Explore Andelyn Biosciences's tech stack below.

  • Hotjar
    Analytics
  • jsDelivr
    Content Delivery Network
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Google Font API
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • PHP
    Programming Languages
  • Linkedin
    Widgets

Media & News

Andelyn Biosciences's Email Address Formats

Andelyn Biosciences uses at least 1 format(s):
Andelyn Biosciences Email FormatsExamplePercentage
First.Last@andelynbio.comJohn.Doe@andelynbio.com
94%
FirstLast@andelynbio.comJohnDoe@andelynbio.com
4%
Last@andelynbio.comDoe@andelynbio.com
1%
F-Last@andelynbio.comJ-Doe@andelynbio.com
1%

Frequently Asked Questions

Where is Andelyn Biosciences's headquarters located?

Minus sign iconPlus sign icon
Andelyn Biosciences's main headquarters is located at 1180 Arthur E. Adams Dr. Columbus, Ohio 43221 US. The company has employees across 2 continents, including North AmericaEurope.

What is Andelyn Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Andelyn Biosciences's official website is andelynbio.com and has social profiles on LinkedIn.

How much revenue does Andelyn Biosciences generate?

Minus sign iconPlus sign icon
As of August 2024, Andelyn Biosciences's annual revenue reached $35M.

What is Andelyn Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Andelyn Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Andelyn Biosciences have currently?

Minus sign iconPlus sign icon
As of August 2024, Andelyn Biosciences has approximately 215 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: W. M.Chief Financial Officer: A. L.Vice President Information Technology: B. H.. Explore Andelyn Biosciences's employee directory with LeadIQ.

What industry does Andelyn Biosciences belong to?

Minus sign iconPlus sign icon
Andelyn Biosciences operates in the Biotechnology Research industry.

What technology does Andelyn Biosciences use?

Minus sign iconPlus sign icon
Andelyn Biosciences's tech stack includes HotjarjsDelivrMySQLFont AwesomeGoogle Font APIjQuery UIPHPLinkedin.

What is Andelyn Biosciences's email format?

Minus sign iconPlus sign icon
Andelyn Biosciences's email format typically follows the pattern of . Find more Andelyn Biosciences email formats with LeadIQ.

How much funding has Andelyn Biosciences raised to date?

Minus sign iconPlus sign icon
As of August 2024, Andelyn Biosciences has raised $5M in funding. The last funding round occurred on Feb 08, 2022 for $5M.

When was Andelyn Biosciences founded?

Minus sign iconPlus sign icon
Andelyn Biosciences was founded in 2020.
Andelyn Biosciences

Andelyn Biosciences

Biotechnology ResearchOhio, United States201-500 Employees

Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope into Reality™.   Our capabilities span viral vector process and analytical development, adherent and suspension based GMP drug substance manufacturing up to 2,000L, as well as GMP plasmid process development and GMP manufacturing.  We are located in Columbus, OH, USA. 

With more than 20 years of pioneering experience in viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with extensive expertise.  We have produced GMP material for over 75 worldwide clinical trials in addition to over 450 cGMP clinical batches and more than 2,000 research-grade productions. 

Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. 

Our 180,000 sq ft clinical and commercial manufacturing facility comprises 16 upstream production suites for customization of new and tech transferred programs.  Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Section iconCompany Overview

Headquarters
1180 Arthur E. Adams Dr. Columbus, Ohio 43221 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
201-500

Section iconFunding & Financials

  • $5M

    Andelyn Biosciences has raised a total of $5M of funding over 1 rounds. Their latest funding round was raised on Feb 08, 2022 in the amount of $5M.

  • $10M$50M

    Andelyn Biosciences's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $5M

    Andelyn Biosciences has raised a total of $5M of funding over 1 rounds. Their latest funding round was raised on Feb 08, 2022 in the amount of $5M.

  • $10M$50M

    Andelyn Biosciences's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.